Halozyme Therapeutics, Inc.

HALO

NASDAQ

Healthcare

Biotechnology

San Diego, CA, US350 employeeshalozyme.com

$64.47

-0.93(-1.42%)

Mkt Cap $7.6B

$47.91

$81.23

52-Week Range

At a Glance

AI-generated

Halozyme Therapeutics, Inc.

Revenue breakdown: Royalty (41.1%), Product (21.3%), Proprietary Products Sales (10.7%).

8-K

Halozyme Therapeutics, Inc. filed an 8-K on March 12, 2026, with Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, as indicated by the external item hint. Exhibit 99.1 is a press release dated March 12, 2026.

$7.6B

Market Cap

$1.4B

Revenue

$318M

Net Income

Employees350

Fundamentals

How The Business Makes Money

Revenue by Segment

Royalty41.1%($1.9B)

Product21.3%($981M)

Proprietary Products Sales10.7%($492M)

Collaborative Agreements8.1%($374M)

Bulk R Hu PH207.3%($335M)

Event Based Development And Regulatory Milestone And Other Fees4.1%($189M)

Device Partnered Products3.3%($154M)

Salesbasedmilestone2.2%($100M)

Upfront Fees1%($47M)

Device Licensing And Development0.8%($38M)

Revenue by Geography

US64.8%($2.1B)

CH19.7%($638M)

BE11.1%($360M)

JP2.5%($80M)

Foreign Other1.9%($62M)

Activity

What Changed Recently

Management Change

Mar 11, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (c) On Marc

Financial Results

Feb 16, 2026

of this report and shall not be deemed “ filed ” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “ Exchange Act ” ) or other

Financial Results

Jan 27, 2026

of this report and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise

Peer Companies

Company	Price	Change	Market Cap	P/E
JAZZJazz Pharmaceuticals plc	$186.84	-0.76%	$11.5B	-31.2
HSICHenry Schein, Inc.	$74.00	+1.31%	$8.7B	22.0
CYTKCytokinetics, Incorporate...	$66.61	-0.02%	$8.2B	-9.5
ATRAptarGroup, Inc.	$126.21	-0.43%	$8.1B	20.6
ABVXAbivax S.A.	$118.21	+2.82%	$7.8B	-33.0
GRFSGrifols, S.A.	$8.23	-0.24%	$7.0B	15.2
MRUSMRUS	$90.00	+0.00%	$6.8B	—
RYTMRhythm Pharmaceuticals, I...	$86.33	-2.04%	$5.9B	-28.8

Analyst View

Company Profile

CIK0001159036

ISINUS40637H1095

CUSIP40637H109

Phone858 794 8889

Address11388 Sorrento Valley Road, San Diego, CA, 92121, US

SEC EDGAR